The influence of pre-diagnostic allostatic load on mortality after incident colorectal cancer

Allostatic load is an emerging stress biomarker capturing immune, cardiovascular, and metabolic dysregulations. We evaluated associations between allostatic load and mortality after colorectal cancer (CRC) diagnosis, comparing allostatic load to metabolic syndrome to determine if including additional domains beyond metabolism strengthens associations with mortality. Southern Community Cohort Study participants who developed incident CRC after enrollment (2002-2009) were included; most self-identified as Black (69%) and report <$15,000 annual household income (55%). Enrollment samples were analyzed for immune, metabolic, and cardiovascular biomarkers. A standard metabolic syndrome definition was used (3/5 traits); most (N=1007) had available information to calculate metabolic syndrome. To calculate allostatic load, biomarkers above clinical risk cutoffs were summed; counts above median indicated high allostatic load (4/10 traits). A subsample of 303 had additional information to calculate allostatic load. Mortality was ascertained through 2020 via National Death Index linkage. Multivariate-adjusted Cox models estimated hazard ratios and 95% confidence intervals (HR[95%CI]). High allostatic load was associated with higher risk of all-cause (1.81[1.25-2.62]) and CRC-specific mortality (HR:1.81[1.07-3.07]). The latter attenuated after controlling for health behaviors (HR:1.57[0.91-2.70]). Metabolic syndrome was not associated with mortality (all-cause: 1.06[0.88-1.28]; CRC-specific: 1.08[0.83-1.40]). Allostatic load may be a clinically actionable biomarker to readily identify cancer patients with comorbidity.

Authors

Institutions

Publication Details

Journal
American Journal of Epidemiology
Published
2026-11-19
DOI
https://doi.org/10.1093/aje/kwag296
Primary Topic
Health disparities and outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The influence of pre-diagnostic allostatic load on mortality after incident colorectal cancer

Shaneda Warren Andersen, Amy Trentham‐Dietz, Amy Louise Cochran, Doratha Armenthus Byrd et al.
American Journal of Epidemiology
Health disparities and outcomes
article

The influence of pre-diagnostic allostatic load on mortality after incident colorectal cancer

Shaneda Warren Andersen, Amy Trentham‐Dietz, Amy Louise Cochran, Doratha Armenthus Byrd, Melissa A. Rosenkranz, Tiffany L. Carson, Zoe L. Walts, Martha J. Shrubsole, Anne D. Letocha, Oluwatoyosi Ogunmuyiwa
article en

Abstract

Allostatic load is an emerging stress biomarker capturing immune, cardiovascular, and metabolic dysregulations. We evaluated associations between allostatic load and mortality after colorectal cancer (CRC) diagnosis, comparing allostatic load to metabolic syndrome to determine if including additional domains beyond metabolism strengthens associations with mortality. Southern Community Cohort Study participants who developed incident CRC after enrollment (2002-2009) were included; most self-identified as Black (69%) and report <$15,000 annual household income (55%). Enrollment samples were analyzed for immune, metabolic, and cardiovascular biomarkers. A standard metabolic syndrome definition was used (3/5 traits); most (N=1007) had available information to calculate metabolic syndrome. To calculate allostatic load, biomarkers above clinical risk cutoffs were summed; counts above median indicated high allostatic load (4/10 traits). A subsample of 303 had additional information to calculate allostatic load. Mortality was ascertained through 2020 via National Death Index linkage. Multivariate-adjusted Cox models estimated hazard ratios and 95% confidence intervals (HR[95%CI]). High allostatic load was associated with higher risk of all-cause (1.81[1.25-2.62]) and CRC-specific mortality (HR:1.81[1.07-3.07]). The latter attenuated after controlling for health behaviors (HR:1.57[0.91-2.70]). Metabolic syndrome was not associated with mortality (all-cause: 1.06[0.88-1.28]; CRC-specific: 1.08[0.83-1.40]). Allostatic load may be a clinically actionable biomarker to readily identify cancer patients with comorbidity.

American Journal of Epidemiology
University of Wisconsin–Madison (US), Vanderbilt University (US), Moffitt Cancer Center (US), University of Wisconsin Carbone Cancer Center (US), Vanderbilt-Ingram Cancer Center (US), Vanderbilt University Medical Center (US)
Health disparities and outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon